Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2010-12-09 Director's Dealing
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
Director's Dealing 2010
Director's Dealing
2010-12-09 English
4
Director's Dealing
2010-12-03 English
Regulatory Filings 2010
Regulatory Filings Classification · 90% confidence The provided document text appears to be an encoded or binary attachment (likely a PDF or similar file) embedded within the text, as indicated by the 'begin 644 filename1.pdf' and the presence of non-readable characters. There is no clear textual content, no mention of regulatory bodies, form names, fiscal periods, or report titles. The document length is 15,000 characters, but the content is not human-readable text or a report itself. Given the lack of readable content and the nature of the text, this is likely a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2010-11-29 English
4
Director's Dealing
2010-11-26 English
Regulatory Filings 2010
Regulatory Filings Classification · 95% confidence The document is a letter from Balchem Corporation responding to comments from the SEC regarding their Form 10-K for the fiscal year ended December 31, 2009, and Form 10-Q for the period ended June 30, 2010. It discusses detailed accounting policies, financial statement notes, and disclosures related to these filings. The document is not the actual 10-K or 10-Q report but a correspondence addressing SEC comments on those filings. It contains detailed responses and sample disclosures but does not itself present the full financial statements or comprehensive report. Therefore, it is best classified as a Regulatory Filing (RNS), which covers correspondence and compliance documents that do not constitute the full report itself.
2010-11-23 English
Regulatory Filings 2010
Regulatory Filings Classification · 90% confidence The document text appears to be a large block of encoded or compressed data, possibly a binary or PDF file content encoded in ASCII. There are no clear textual indicators such as report titles, fiscal period dates, regulatory body mentions, or specific form names. The length is about 15,000 characters, which is substantial, but the content is not human-readable and does not contain any discernible financial statements, management discussion, or other report content. Given the lack of identifiable content and the nature of the text, it is most appropriate to classify this as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other specific categories.
2010-11-09 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.